Gene · 974
Papers4,161
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 4,161
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Single-Cell transcriptomic profiles of peripheral blood immune cells reveal early monocyte and platelet activation in the transition from high-risk states to clinical sepsis. | Sci Rep | 2025 | 40998960 | PubTator, text mining | PubMed |
| Genomic landscape of IgM-MGUS and patients with stable or progressive asymptomatic Waldenström macroglobulinemia. | Blood | 2025 | 40997305 | PubTator, text mining | PubMed |
| Enhancement of lentiviral vectors gene delivery against VEGFR2 expressing cells by co-display of the binding and fusogenic moieties: a two molecules targeting approach. | Virol J | 2025 | 40993690 | PubTator, text mining | PubMed |
| Tertiary lymphoid structures in Merkel cell carcinoma facilitate naïve and central memory T-cell infiltration linked to immunotherapy response. | J Immunother Cancer | 2025 | 40992783 | PubTator, text mining | PubMed |
| LTO1 and YAE1 regulate MHC-I expression via nonsense-mediated RNA decay in tumor cells. | J Immunother Cancer | 2025 | 40987494 | PubTator, text mining | PubMed |
| Mechanisms of Resistance to CAR T-Cells and How to Overcome Them. | Methods Protoc | 2025 | 40981226 | PubTator, text mining | PubMed |
| Tumour Single-Cell Bioinformatics: From Immune Profiling to Molecular Dynamics. | J Cell Mol Med | 2025 | 40954554 | PubTator, text mining | PubMed |
| The effective and safe administration of Epcoritamab in relapsed CD19-CD5+ DLBCL following CAR-T therapy. | Blood Cell Ther | 2025 | 40927278 | PubTator, text mining | PubMed |
| HIV-1 manipulates CD96 on CD4+ T cells to subvert antiviral immunity. | Sci Adv | 2025 | 40911682 | PubTator, text mining | PubMed |
| Evaluating the causal effect of circulating proteome on the risk of Juvenile idiopathic arthritis: an omics pipeline study. | Pediatr Rheumatol Online J | 2025 | 40898345 | PubTator, text mining | PubMed |
| Prognostic value of clinicopathological features of diffuse large B-cell lymphoma with bone marrow involvement. | Int J Biol Markers | 2025 | 40891690 | PubTator, text mining | PubMed |
| Longitudinal liquid biopsy identifies an early predictive biomarker of immune checkpoint blockade response in head and neck squamous cell carcinoma. | Nat Commun | 2025 | 40890155 | PubTator, text mining | PubMed |
| Treatment outcomes and CNS relapse risk in patients with primary cutaneous DLBCL, leg-type in the rituximab era. | Blood Cancer J | 2025 | 40883287 | PubTator, text mining | PubMed |
| IgM and IgG1 B cell receptors differentially affect B cell fates and dictate the pathogenesis of mature B cell lymphomas. | Sci Adv | 2025 | 40880486 | PubTator, text mining | PubMed |
| T cell exhaustion‑related gene CD79B predicts prognosis, inhibits malignant progression and promotes tumor‑associated macrophage M1‑like polarization in lung adenocarcinoma. | Oncol Rep | 2025 | 40878933 | PubTator, text mining | PubMed |
| Reprogramming the tumor microenvironment with c-MYC-based gene circuit platform to enhance specific cancer immunotherapy. | Nat Commun | 2025 | 40858620 | PubTator, text mining | PubMed |
| Granular acute lymphocytic leukemia : a case report and literature review. | Discov Oncol | 2025 | 40856917 | PubTator, text mining | PubMed |
| Multi-omic identification of perineurial hyperplasia and lipid-associated nerve macrophages in human polyneuropathies. | Nat Commun | 2025 | 40849297 | PubTator, text mining | PubMed |
| Synthetic Lethal Combinations of DNA Repair Inhibitors and Genotoxic Agents to Target High-Risk Diffuse Large B Cell Lymphoma. | Hematol Oncol | 2025 | 40847617 | PubTator, text mining | PubMed |
| B Cell Tolerance and BCR Signaling Dysregulation in NF155-Mediated Autoimmune Nodopathies. | bioRxiv | 2025 | 40832342 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/974/papers?page=8